The Expanding Role of Real-World Evidence Trials in Health Care Decision Making-Reference-Cited by-同舟云学术

The Expanding Role of Real-World Evidence Trials in Health Care Decision Making

Published:2019-03-06 Issue:1 Volume:14 Page:174-179
ISSN:1932-2968
Container-title:Journal of Diabetes Science and Technology
language:en
Short-container-title:J Diabetes Sci Technol

Author:

Klonoff David C.¹

Affiliation:

1. Diabetes Research Institute; Mills-Peninsula Health Services, San Mateo, CA, USA

Abstract

Real-world evidence (RWE) is the clinical evidence about benefits or risks of medical products derived from analyzing real world data (RWD), which are data collected through routine clinical practice. This article discusses the advantages and disadvantages of RWE studies, how these studies differ from randomized controlled trials (RCTs), how to overcome barriers to current skepticism about RWE, how FDA is using RWE, how to improve the quality of RWE, and finally the future of RWE trials.

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1932296819832653

Reference38 articles.

1. Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician

2. Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol

3. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers

4. Multidimensional Evidence Generation and FDA Regulatory Decision Making

5. Mining Personal Data Using Smartphones and Wearable Devices: A Survey

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A community health worker led diabetes self-management education program: Reducing patient and system burden;Journal of Diabetes and its Complications;2024-08

2. Key results from observational studies and real‐world evidence of sodium‐glucose cotransporter‐2 inhibitor effectiveness and safety in reducing cardio‐renal risk;Diabetes, Obesity and Metabolism;2024-06-10

3. A review of the literature on the new European Medical Device Regulations requirements for increased clinical evaluation;International Journal of Pharmaceutical and Healthcare Marketing;2024-05-13

4. Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing–remitting multiple sclerosis?;Pharmacoepidemiology and Drug Safety;2024-05

5. Clinical trials are becoming more complex: a machine learning analysis of data from over 16,000 trials;Scientific Reports;2024-02-12